期刊文献+

Effects of Yishendaluo decoction on axonal degeneration,inflammatory reaction,and neurological function in a mouse model of experimental autoimmune encephalomyelitis 被引量:6

Effects of Yishendaluo decoction on axonal degeneration,inflammatory reaction,and neurological function in a mouse model of experimental autoimmune encephalomyelitis
下载PDF
导出
摘要 BACKGROUND: Yishendaluo decoction reduces production of inflammatory mediators, relieves damage due to inflammatory reactions, and improves neural functions during experimental autoimmune encephalomyelitis. OBJECTIVE: To investigate the effects of Yishendaluo decoction on a mouse model of experimental autoimmune encephalomyelitis. DESIGN, TIME AND SETTING: The randomized, controlled, neuropathological, and molecular biological animal study was performed at the Key Laboratory of Chinese Internal Medicine, Ministry of Education, Dongzhimen Hospital of Beijing University of Chinese Medicine and Center for Neuroinformatics, General Hospital of Chinese PLA from 2005 to 2006. MATERIALS: Yishendaluo decoction pieces consisting of prepared rehmannia root, colla comus cervi, cape jasmine fruit, and grassleaf sweetflag rhizome were purchased from the Dongzhimen Hospital of Beijing University of Chinese Medicine. Rabbit anti-mouse β-amyloid precursor protein and p38 polyclonal antibody (Zhongshan Goldenbridge Biotechnology, China), as well interferon-y and interleukin-4 ELISA kit (Boster, China), were used in this study. METHODS: A total of 96 healthy, female, SJL/J mice, aged 8 12 weeks, were equally and randomly assigned to normal, model, hormone, and Chinese medicine groups. A total of 0.2 mL antigen preparation, supplemented with 150 μg PLP 139-151 and 400 μg H37RA, was subcutaneously injected into the upper abdomen of mice from the model, hormone, and Chinese medicine groups. Mouse models of experimental autoimmune encephalomyelitis were established by intravenous injection of 0.1 mL Bordetella pertussis solution containing 0.6 × 10^6 Bordetella pertussis at days 1 and 3. Mice from the model, Chinese medicine, and hormone groups were respectively subjected to 0.2 mL saline, 2 g/kg Yishendaluo decoction, and 0.078 mg/kg prednisone acetate, once daily for 14 consecutive days. Mice from the normal group were left intact. MAIN OUTCOME MEASURES: Pathological changes were observed using hematoxylin-eosin staining and Luxol fast blue staining. Expression of β-amyloid precursor protein and p38 protein was determined by immunohistochemistry. Levels of interferon-y and interleukin-4 were detected by ELISA. Behavioral changes were assessed in mice according to scores of neurological function. RESULTS: A few inflammatory cell infiltration, nerve fiber breakage and slight demyelination were detected in the central nervous system of mice from the Chinese medicine and hormone groups compared with the model group. Expression of β-amyloid precursor protein and p38 protein was significantly diminished in the central nervous system of mice from the Chinese medicine and hormone groups compared with the model group (P 〈 0.05 or P 〈 0.01), and the decrease was greatest in the Chinese medicine group. The decrease in mouse weight was not significant, and neurological function scores were less in the Chinese medicine and hormone groups compared with the model group (P 〈 0.05 or P 〈 0.01). Interferon-y levels were significantly reduced (P 〈 0.01), and interleukin-4 levels were significantly increased (P 〈 0.01) in the brains of the Chinese medicine and hormone groups, compared with the model group. CONCLUSION: Yishendaluo decoction improved neurological function in mice with experimental autoimmune encephalomyelitis by downregulating β-amyloid precursor protein expression, resistingaxonal degeneration, and relieving inflammatory reaction. The anti-inflammatory mechanism was regulated by inhibition of the p38 mitogen-activated protein kinase signal pathway. BACKGROUND: Yishendaluo decoction reduces production of inflammatory mediators, relieves damage due to inflammatory reactions, and improves neural functions during experimental autoimmune encephalomyelitis. OBJECTIVE: To investigate the effects of Yishendaluo decoction on a mouse model of experimental autoimmune encephalomyelitis. DESIGN, TIME AND SETTING: The randomized, controlled, neuropathological, and molecular biological animal study was performed at the Key Laboratory of Chinese Internal Medicine, Ministry of Education, Dongzhimen Hospital of Beijing University of Chinese Medicine and Center for Neuroinformatics, General Hospital of Chinese PLA from 2005 to 2006. MATERIALS: Yishendaluo decoction pieces consisting of prepared rehmannia root, colla comus cervi, cape jasmine fruit, and grassleaf sweetflag rhizome were purchased from the Dongzhimen Hospital of Beijing University of Chinese Medicine. Rabbit anti-mouse β-amyloid precursor protein and p38 polyclonal antibody (Zhongshan Goldenbridge Biotechnology, China), as well interferon-y and interleukin-4 ELISA kit (Boster, China), were used in this study. METHODS: A total of 96 healthy, female, SJL/J mice, aged 8 12 weeks, were equally and randomly assigned to normal, model, hormone, and Chinese medicine groups. A total of 0.2 mL antigen preparation, supplemented with 150 μg PLP 139-151 and 400 μg H37RA, was subcutaneously injected into the upper abdomen of mice from the model, hormone, and Chinese medicine groups. Mouse models of experimental autoimmune encephalomyelitis were established by intravenous injection of 0.1 mL Bordetella pertussis solution containing 0.6 × 10^6 Bordetella pertussis at days 1 and 3. Mice from the model, Chinese medicine, and hormone groups were respectively subjected to 0.2 mL saline, 2 g/kg Yishendaluo decoction, and 0.078 mg/kg prednisone acetate, once daily for 14 consecutive days. Mice from the normal group were left intact. MAIN OUTCOME MEASURES: Pathological changes were observed using hematoxylin-eosin staining and Luxol fast blue staining. Expression of β-amyloid precursor protein and p38 protein was determined by immunohistochemistry. Levels of interferon-y and interleukin-4 were detected by ELISA. Behavioral changes were assessed in mice according to scores of neurological function. RESULTS: A few inflammatory cell infiltration, nerve fiber breakage and slight demyelination were detected in the central nervous system of mice from the Chinese medicine and hormone groups compared with the model group. Expression of β-amyloid precursor protein and p38 protein was significantly diminished in the central nervous system of mice from the Chinese medicine and hormone groups compared with the model group (P 〈 0.05 or P 〈 0.01), and the decrease was greatest in the Chinese medicine group. The decrease in mouse weight was not significant, and neurological function scores were less in the Chinese medicine and hormone groups compared with the model group (P 〈 0.05 or P 〈 0.01). Interferon-y levels were significantly reduced (P 〈 0.01), and interleukin-4 levels were significantly increased (P 〈 0.01) in the brains of the Chinese medicine and hormone groups, compared with the model group. CONCLUSION: Yishendaluo decoction improved neurological function in mice with experimental autoimmune encephalomyelitis by downregulating β-amyloid precursor protein expression, resistingaxonal degeneration, and relieving inflammatory reaction. The anti-inflammatory mechanism was regulated by inhibition of the p38 mitogen-activated protein kinase signal pathway.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第11期928-934,共7页 中国神经再生研究(英文版)
基金 the National Natural Science Foundation of China,No.30672692
关键词 autoimmune encephalomyelitis multiple sclerosis Yishendaluo decoction β-amyloid precursor protein autoimmune encephalomyelitis multiple sclerosis Yishendaluo decoction β-amyloid precursor protein
  • 相关文献

参考文献2

二级参考文献29

  • 1林嘉友.实验性变态反应性脑脊髓炎小鼠模型[J].中国免疫学杂志,1994,10(1):39-40. 被引量:11
  • 2Meyaard L, Adema GJ, Chang C, et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes[J]. Immunity,1997,7:283.
  • 3Martin AM, Kulski JK, Witt C, et al. Leukocyte Ig-like receptor complex ( LRC ) in mice and man [ J ]. Trends Immunol, 2002,23:81.
  • 4Xu MJ, Zhao RX, Zhao ZJ,et al. Identification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cells [J] .J Biol Chem,2000,275:17440.
  • 5Sathish JG, Johnson KG, Fuller KJ, et al. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells[J]. J Immunol,2001,166 : 1763.
  • 6Meyaard L, Hurenkamp J, Clevers H, et al. Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells[J] .J Immunol, 1999,162:5800.
  • 7van der Vuurst de Vries AR, Clevers H, Logtenberg T, et al. Leukocyte-associated immunoglobulin-like receptor-I (LAIR-1)is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling [J]. Eur J Immunol, 1999,29: 3160.
  • 8Poggi A, Pellegatta F, Leone BE, et al. Engagement of the leukocyte-Msceiated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias[J].Eur J Immunol,2000,30:2751.
  • 9Kannourakis G, Johnson GR,Begley CG,et al. Enhancement of in vitro β-Thalassemic and normal hematopoiesis by a noncytotoxic monnclonal antibody,9.1C3: evidence for negative regulation of hematopoiesis by monocytes and natund killer cells[J]. Blood, 1988,72:1124.
  • 10Zocchi MR, Pellegatta F, Pierri I, et al. Leukocyte-associated Ig-like receptor-1 prevent granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary aute myeloid leukemia cells[J] .Eur J Immunol,2001,31:3667.

共引文献10

同被引文献66

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部